The Union ministry has banned Patanjali from selling Coronil as a cure for COVID-19.

Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19, it said.  At a press conference in Haridwar, Ramdev insisted the ministry has said that Patanjali did an appropriate job for COVID-19 management.

 However, on Wednesday Yoga guru Ramdev's Patanjali Ayurved stated that there are no Ayush ministry constraints on selling 'Coronil', a drug the company recently inaugurated as medicine for COVID-19 but is now calling it a product to regulate the disease.

"I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today," he added, citing Coronil and the two other products Patanjali is promoting together.

Ramdev told the Union ministry had asked him to use the term 'COVID-19 management' in place of 'COVID-19 treatment' and he is obeying the instruction.

Even while backtracking on characterizing Coronil as a treatment for COVID-19, the company stuck to its statement that the drug's examination on mild to moderately ill patients was successful.

Its press note said the examination, conducted after the necessary permissions, showed 100 percent recovery of patients under seven days.

It started that the Ayush ministry has categorically decided that Patanjali had suitably worked on COVID-19 management.

Now there is no disparity of opinion between Ayush ministry and Patanjali, it added.

According to the ministry, Patanjali is authorized to manufacture and dispense its Diva Coronil tablet, Divya Swasari Vati and Divya Anu Talia across India, as per the manufacturing licences awarded by State Licensing Authority, Ayurvedic and Unani Services, Govt of Uttarakhand, it said.

The Uttarakhand department was among the agencies which had challenged Patanjali's claim to have formulated a drug to cure COVID-19. It said the company had only been given a license to produce an immunity booster